NL-OMON54327招募中不适用
eiden Thrombosis Recurrence Risk Prevention: Tailored treatment after a first venous thromboembolism: (L-TRRiP study) - L-TRRiP study
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 1,600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Provision of informed consent prior to any study specific procedures.
- •2. Be diagnosed with a first confirmed symptomatic deep vein thrombosis
- •(including distal vein thrombosis, in Dutch ' kuitvenetrombose') or pulmonary
- •embolism with an indication for treatment with anticoagulant therapy for at
- •least 3 months as prescribed by their treating physician.
- •3. Be aged 18 years or above.
排除标准
- •1. Patients with active cancer (i.e. cancer diagnosis within six months before
- •VTE (excluding basal-cell or squamous-cell carcinoma of the skin), recently
- •recurrent or progressive cancer or any cancer that required anti-cancer
- •treatment within six months before the venous thromboembolism was diagnosed) or
- •antiphospholipid syndrome
- •2. Patients who need to continue anticoagulant treatment for another indication
- •(e.g. atrial fibrillation).
- •3. Patients with a strong indication for long-term antiplatelet therapy despite
- •oral anticoagulation (e.g. those with recent STEMI)
- •4. Patients with COVID-19 associated VTE (i.e. hospital admission because of
- •COVID-19 <3 months before VTE) or vaccine-induced immune thrombotic
- •thrombocytopenia (VITT)
- •5. Patients in whom the risk of bleeding is deemed extremely high by the
- •treating physician, necessitating discontinuation of anticoagulant treatment
- •for the first VTE after the initial 3 months or even during the initial 3
研究者
相似试验
招募中
Unknown
eiden Thrombosis Recurrence Risk Preventio<p>Venous thromboembolism (deep vein thrombosis and pulmonary embolism)</p>10014523VTENL-OMON26314eiden University Medical Centre608
已完成
不适用
Thrombosis Prevention TrialISRCTN63594484Sponsor not defined - Record provided by the Medical Research Council (UK)5,499
已完成
2 期
Preventing Recurrence of Thromboembolic Events Through Coordinated Treatment in the District of ColumbiaStrokeNCT00703274Georgetown University230
已完成
不适用
Prevention of Thromboembolic Events – European Registry in Venous ThromboembolismMedDRA - Venous ThromboembolismI82Other venous embolism and thrombosisDRKS00004795Daiichi-Sankyo Europe GmbH3,544
招募中
不适用
Prevention of local thromboembolic complications during continuous infusion of coagulation factor concentrates: parallel infusion of saline or heparin?Continuous infusionCoagulation factor concentratesHeparinSalineNL-OMON23399MC utrecht42